Evogene LTD Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
Leon Recanati, a Director of Evogene Ltd., received 2,500 shares of common stock on September 4, 2026.
NASDAQ
Nir Nimrodi, a Director of Evogene Ltd., received 10,000 shares of common stock on September 4, 2026.
NASDAQ
Adrian John Percy, a Director of Evogene Ltd., received 2,500 shares of common stock on September 4, 2026.
NASDAQ
Dan Michael Falk, a Director of Evogene Ltd., received 2,500 shares of common stock on September 4, 2026.
NASDAQ
Leon Recanati, a Director of Evogene Ltd., purchased 460,000 shares of common stock on August 11, 2026 for $0.64 per share.